Yi Larson's Net Worth

$3.42 Million

Estimate Recalculated Jul 12, 2024 04:17PM EST

Who is Yi Larson?

Yi Larson has an estimated net worth of $3.42 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., LianBio, Olema Pharmaceuticals, Inc., and RayzeBio, Inc..

SEC CIK

Yi Larson's CIK is 0001785987

Past Insider Trading and Trends

2021 was Yi Larson's most active year for acquiring shares with 9 total transactions. Yi Larson's most active month to acquire stocks was the month of January. 2021 was Yi Larson's most active year for disposing of shares, totalling 11 transactions. Yi Larson's most active month to dispose stocks was the month of January. 2021 saw Yi Larson paying a total of $1,620,900.00 for 337,739 shares, this is the most they've acquired in one year. In 2021 Yi Larson cashed out on 60,000 shares for a total of $3,801,917.69, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc. No price found

EVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+170.75%
4.62K
—
—
7.32K
Feb 8
Form 4
—
0
$90.38
-$2,181,017.69
2.7K
Scheduled
Feb 1 - Feb 2
Form 4
—
0
—
—
0
Jan 6
Form 4
∞
2.22K
$45.00
$99,990.00
2.22K
Sep 10
Form 4
—
0
—
—
0
Aug 26
Form 3
—
0
—
—
0
No matching records found

LianBio (LIAN) Snapshot price: $4.11

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
325.9K
—
—
325.9K
Mar 29
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Oct 31
Form 3
—
0
—
—
0
No matching records found

Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $15.315

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 16
Form 4/A
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Apr 5
Form 3
—
0
—
—
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 26
Form 3
—
0
—
—
0
No matching records found